Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Hazes

Showing results (91-100 of 94) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 94 results.
Annals of the Rheumatic Diseases|May 3, 2014
Randomised comparison of initial triple DMARD therapy with methotrexate monotherapy in combination with low-dose glucocorticoid bridging therapy; 1-year data of the tREACH trialP H de Jong, J M Hazes, H K Han, et al.
Annals of the Rheumatic Diseases|June 9, 2012
Induction therapy with a combination of DMARDs is better than methotrexate monotherapy: first results of the tREACH trialP H de Jong, J M Hazes, P J Barendregt, et al.
Arthritis and Rheumatism|November 12, 1998
No increased risk of malignancies and mortality in cyclosporin A-treated patients with rheumatoid arthritisB E van den Borne, R B Landewé, I Houkes, et al.
Annals of the Rheumatic Diseases|September 10, 2020
Two-year cost effectiveness between two gradual tapering strategies in rheumatoid arthritis: cost-utility analysis of the TARA trialElise van Mulligen, Angelique E Weel, Tjallingius Martijn Kuijper, et al.
Pageof 10

Showing results (91-100 of 94) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 94 results.
Annals of the Rheumatic Diseases|May 3, 2014
Randomised comparison of initial triple DMARD therapy with methotrexate monotherapy in combination with low-dose glucocorticoid bridging therapy; 1-year data of the tREACH trialP H de Jong, J M Hazes, H K Han, et al.
Annals of the Rheumatic Diseases|June 9, 2012
Induction therapy with a combination of DMARDs is better than methotrexate monotherapy: first results of the tREACH trialP H de Jong, J M Hazes, P J Barendregt, et al.
Arthritis and Rheumatism|November 12, 1998
No increased risk of malignancies and mortality in cyclosporin A-treated patients with rheumatoid arthritisB E van den Borne, R B Landewé, I Houkes, et al.
Annals of the Rheumatic Diseases|September 10, 2020
Two-year cost effectiveness between two gradual tapering strategies in rheumatoid arthritis: cost-utility analysis of the TARA trialElise van Mulligen, Angelique E Weel, Tjallingius Martijn Kuijper, et al.
Pageof 10